Posted on 1 September 2014
CENTER-TBI brings the latest technologies and many of the world's leading TBI experts together in a much needed effort to tackle Traumatic Brain Injury.
Improvement found in cognitive function following treatment with antidepressant drug independent of depression symptoms
Posted on 20 August 2014
Greer and colleagues have reported that 12 weeks treatment with the antidepressant drug Duloxetine (a serotonin and noradrenaline reuptake inhibitor) improved cognition measured using the CANTAB task in patients with MDD with subjective reports of cognitive impairment.
Cambridge Cognition and Altreos Research Partners, Inc. join forces as FDA guidelines drive demand for Human Abuse Liability studies
Posted on 13 August 2014
Cambridge Cognition, the global leader in touchscreen cognitive assessments for clinical trials, has formed a scientific partnership with Altreos Research Partners, Inc., a leading provider of scientific, regulatory and operational input on abuse liability assessments.
Posted on 29 July 2014
A new study conducted by researchers at the University of North Carolina is to examine the effect of the omega-6 to omega-3 fatty acid ratio on age-related changes in executive functions in children and older adults.